The Leahy-Smith America Invents Act (“AIA”) created three new procedures to be presided over by the newly created Patent Trial and Appeal Board (“PTAB”).  Two […]

While the early hypothesis that chimeric antigen receptors (CARs) could be expressed in T-cells (CAR T-cells) for use as therapeutic agents was more than three […]

With the passage of the America Invents Act (AIA), the U.S. moved from a First-To-Invent system to a First-Inventor-To-File system in order to harmonize the […]